ScholarIQanswers from OpenAlex

Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients

PaperCitations, authors & open-access status

Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients have?

ScholarIQcitation count

Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients has 221 citations in the OpenAlex counts ScholarIQ stores.

When was Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients published?

ScholarIQyear

Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients has 2010 year in the ScholarIQ index.

What is the open-access status of Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients?

ScholarIQoa status

Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients has closed oa status in the ScholarIQ index.

What is the DOI of Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients?

ScholarIQdoi

The DOI for Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients is on the source record.

What is the PMID of Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients?

ScholarIQpmid

The PMID for Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients is on the source record.

What is the OpenAlex record for Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients?

ScholarIQopenalex

The OpenAlex for Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial